Agilon Health Inc. (NYSE: AGL) reported Q3 EPS of ($0.27), $0.12 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.42 billion.

GUIDANCE:

Agilon Health Inc. sees FY2025 revenue of $5.81-5.83 billion, versus the consensus of $6.266 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.